Breast Cancer Clinical Trials in Hong Kong
6 recruitingHong Kong, Hong Kong
Showing 1–6 of 6 trials
Recruiting
Phase 3
OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer
Breast CancerMetastatic Breast CancerAdvanced Breast Cancer+1 more
Olema Pharmaceuticals, Inc.510 enrolled233 locationsNCT06016738
Recruiting
Phase 3
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Breast Cancer
Stemline Therapeutics, Inc.4,220 enrolled524 locationsNCT06492616
Recruiting
Phase 3
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer
Breast Cancer
AstraZeneca625 enrolled315 locationsNCT06103864
Recruiting
Not Applicable
Nurse-led Primary Healthcare Intervention Model in Women's Health Management in Hong Kong
Breast CancerHypertensionOsteoporosis+5 more
The University of Hong Kong1,728 enrolled3 locationsNCT06628388
Recruiting
Not Applicable
Alleviation of Alopecia in Breast Cancer Patient Using Synbiotics Formula
Breast CancerHair Loss
GenieBiome Limited40 enrolled2 locationsNCT06560385
Recruiting
Phase 3
Delayed Sentinel Lymph Node Biopsy in Ductal Cancer in Situ
Breast CancerBreast NeoplasmsSentinel Lymph Node+1 more
Uppsala University500 enrolled9 locationsNCT04722692